Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study
Kirenga et al., Molecular Psychiatry, doi:10.1038/s41380-023-02004-3
https://c19early.org/kirenga2.html